EFFICACY SUSTAINED AFTER DOSE DE-ESCALATION OF CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PATIENTS: POST-HOC ANALYSIS OF THE RAPID 2 OPEN-LABEL EXTENSION
Author(s):
Smolen, J.; Vollenhoven, R. van; Kavanaugh, A.; Luijtens, K.; Heijde, D. van der; Curtis, J.
